Substance Use Disorders Refresh: Nonopioid Substance Use Disorders
August 2023
Substance Use Disorders Refresh: Nonopioid Substance Use Disorders
The landscape of substance use has changed in recent years. While the opioid crisis has captured national attention (see “Responding to the Opioid Crisis” Editor’s Choice collection, July 2023), other substance use disorders affect a greater and increasing proportion of the population. Current trends include rising methamphetamine use, expanding legalization of cannabis, and increases in benzodiazepine prescribing.
This month’s Editor’s Choice Collection provides an update on nonopioid substance use disorders. Barriers to diagnosis and treatment of substance use disorders remain, although coverage for services may be increasing and improving disparities. Research on substance use treatment models in Psychiatric Services has focused on integrating care and specific strategies such as contingency management. Although impacts of the COVID-19 pandemic on substance use and treatment access are still being measured, the pandemic likely resulted in increased substance misuse and decreased access to care.
Browse all Editor’s Choice collections
Specific Substance Use Disorders
Benzodiazepine Use and Misuse Among Adults in the United States
Donovan T.
Maust, M.D., M.S., Lewei A. Lin, M.D., Frederic C. Blow, Ph.D.
2018, Volume 70, Issue 2, pp 97–106
Long-Term Benzodiazepine Use and Discontinuation Among Patients in the U.S. Veterans
Health Administration
Christine Timko, Ph.D., Katherine J. Hoggatt, Ph.D., Aryan Esmaeili, Ph.D., Eleanor
Lewis, Ph.D., Mai Chee Lor, M.P.H., Donovan T. Maust, M.D., Andrea L. Nevedal, Ph.D.
2022, Volume 73, Issue 11, pp 1217–1224
Walking the Benzodiazepine High Wire
Kurt Kroenke, M.D., and Matthew E.
Hirschtritt, M.D., M.P.H.
2022, Volume 74, Issue 1, pp 73–75
Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A
Systematic Review
Corneliu N. Stanciu, M.D., M.R.O., Mary F. Brunette, M.D., Nikhil Teja, M.D., Alan
J. Budney, Ph.D.
2021, Volume 72, Issue 4, pp 429–436
Informed Consent: A Policy Prescription for Communicating Benefit and Risk in State
Medical Marijuana Programs
Erik Messamore, M.D., Ph.D., and Sara E. Dugan, Pharm.D.
2020, Volume 71, Issue 9, pp 941–946
Implementation of Contingency Management at a Large VA Addiction Treatment Center
Hang Ruan, L.I.C.S.W., Cody L. Bullock, Ph.D., Greg M. Reger, Ph.D., M.A.
2017, Volume 68, Issue 12, pp 1207–1209
Smoking Cessation Medication Prescribing for Smokers With and Without Mental Illness
Sarah A. White, M.S.P.H., Elizabeth Stone, M.S.P.H., Karly A. Murphy, M.D., M.H.S.,
Gail L. Daumit, M.D., M.H.S., Emma E. McGinty, Ph.D.
2022, Volume 74, Issue 4, pp 332–340
A Pragmatic Cluster-Randomized Trial of Provider Education and Community Health Worker
Support for Tobacco Cessation
A. Eden Evins, M.D., M.P.H., Corinne Cather, Ph.D., Melissa Culhane Maravic, Ph.D.,
M.P.H., Sally Reyering, M.D., Gladys N. Pachas, M.D., Anne N. Thorndike, M.D., M.P.H.,
Douglas E. Levy, Ph.D., Vicki Fung, Ph.D., Michael A. Fischer, M.D., Kristina Schnitzer,
M.D., M.P.H., Sarah Pratt, Ph.D., Michael D. Fetters, M.D., Bianca Deeb, M.S.W., Kevin
Potter, Ph.D., David A. Schoenfeld, Ph.D.
2023, Volume 74, Issue 4, pp 365–373
Trends in Substance Use
Prevalence of Mental Health Needs, Substance Use, and Co-occurring Disorders Among
People Admitted to Prison
Amanda Butler, Ph.D., Tonia Nicholls, Ph.D., Hasina Samji, Ph.D., Sheri Fabian, Ph.D.,
M. Ruth Lavergne, Ph.D.
2022, Volume 73, Issue 7, pp 737–744
Barriers to Diagnosis and Treatment
Addressing Substance Use in Psychiatric Care: An Old Problem With Renewed Urgency
Yaara Zisman-Ilani, Ph.D., M.A., William R. Smith, M.D., Ph.D., Nathaniel P. Morris,
M.D.
2022, Volume 74, Issue 2, pp 201–203
Uncovering Barriers to Engagement in Substance Use Disorder Care for Medicaid Enrollees
Irene Falgas-Bague, M.D., Ph.D., Jenny Zhen-Duan, Ph.D., Caroline Ferreira, M.A.,
M.Ed., Sara A. Tahanasab, Fernando Cuervo-Torello, B.A., Marie Fukuda, B.A., Sheri
L. Markle, M.I.A., Margarita Alegría, Ph.D.
2023, Volume , Issue , pp –
Access to and Engagement in Substance Use Disorder Treatment Over Time
Junqing
Liu, Ph.D., Amy Storfer-Isser, Ph.D., Tami L. Mark, Ph.D., Tyler Oberlander,
B.A., Constance Horgan, Ph.D., Deborah W. Garnick, Ph.D., Sarah Hudson Scholle, Dr.P.H.
2020, Volume 71, Issue 7, pp 722–725
Medicaid Expansion and Racial-Ethnic Health Care Coverage Disparities Among Low-Income
Adults With Substance Use Disorders
Mark Olfson, M.D., M.P.H., Christine Mauro, Ph.D., Melanie M. Wall, Ph.D., Colleen
L. Barry, Ph.D., M.P.P., C. Jean Choi, M.S., Ramin Mojtabai, M.D., Ph.D.
2022, Volume 74, Issue 6, pp 604–613
New Research on Treatment Approaches
Integration of Substance Use Disorder Treatment Into a Traditional Community Mental
Health Treatment System
Enrique Oviedo, M.D., Ronald F. Means, M.D., Karen Lilley-Haughey, L.C.S.W.-C., Liwei
L. Hua, M.D., Ph.D.
2023, Volume 74, Issue 7, pp 774–777
Sustainment of Integrated Care in Addiction Treatment Settings: Primary Outcomes From
a Cluster-Randomized Controlled Trial
Helene Chokron Garneau, Ph.D., M.P.H., Mehret T. Assefa, Ph.D., M.P.H., Booil Jo,
Ph.D., James H. Ford, Ph.D., Lisa Saldana, Ph.D., Mark P. McGovern, Ph.D.
2022, Volume 73, Issue 3, pp 280–286
Browse all Editor’s Choice collections
Comments and feedback about Editor’s Choice: [email protected]